Welcome to the Commercial Interactions Tool for ECCO 2026.
Note: More than one topic can be selected
Dashboard
Topic(s)
MOA
Efficacy
Dosing
After this conversation, the HCP is now:
Much closer to prescribing Tremfya
Slightly closer to prescribing
No change
Not a target / not relevant
Log Interaction
